EROSKI SCOOP financials
EROSKI SCOOP
959800J76YJMWZP6S661 | Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Revenue | €5.19B | €4.83B |
| Other income | €295.5M | €264.7M |
| Employee benefits expense | €709.0M | €675.6M |
| Raw materials & consumables used | €3.84B | €3.55B |
| Depreciation & amortisation | €272.4M | €264.9M |
| Operating profit (EBIT) | €254.8M | €182.1M |
| Finance costs | €162.6M | €102.2M |
| Profit before tax | €103.5M | €84.9M |
| Income tax expense | -€5.0M | €21.0M |
| Profit for the year | €108.6M | €63.9M |
| — attributable to owners | €47.1M | €42.0M |
| — attributable to NCI | €61.5M | €21.9M |
| Total comprehensive income | €110.2M | €65.6M |
| Cash flow statement | ||
| Cash generated from operations | €422.2M | €439.3M |
| Net cash from operating activities | €401.0M | €425.7M |
| Net cash from investing activities | -€36.0M | -€116.0M |
| Purchase of PP&E (capex) | €95.1M | €109.0M |
| Purchase of intangibles | €14.2M | €11.2M |
| Net cash from financing activities | -€413.3M | -€298.6M |
| Dividends paid | €36.6M | €20.2M |
| Balance sheet | ||
| Total assets | €3.62B | €3.94B |
| Non-current assets | €2.82B | €3.14B |
| Property, plant & equipment | €699.0M | €741.9M |
| Right-of-use assets | €798.9M | €1.05B |
| Intangible assets & goodwill | €850.0M | €846.1M |
| Current assets | €802.6M | €802.5M |
| Inventories | €428.7M | €400.6M |
| Trade & other receivables | €160.5M | €146.7M |
| Cash & equivalents | €167.7M | €216.0M |
| Total equity | €538.9M | €359.5M |
| — attributable to owners | €183.8M | €146.4M |
| Non-controlling interests | €355.0M | €213.0M |
| Non-current liabilities | €1.92B | €2.41B |
| Current liabilities | €1.17B | €1.17B |
| Trade & other payables | €932.2M | €969.9M |
| Deferred tax liabilities | €158.2M | €190.4M |
| Derived metrics | ||
| Free cash flow | €305.9M | €316.7M |
| Operating margin | 4.9% | 3.8% |
| Net margin | 2.1% | 1.3% |
| Return on equity | 20.1% | 17.8% |
| Cash conversion ratio | 3.69× | 6.66× |
| Capex coverage | 4.22× | 3.91× |
| Other reported items | ||
| Accumulated Other Comprehensive Income | €27.9M | €26.2M |
| Adjustments For Decrease Increase In Inventories | -€25.9M | -€33.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€22.5M | €46.0K |
| Adjustments For Depreciation and Amortisation Expense | €272.4M | €264.9M |
| Adjustments For Finance Costs | €156.2M | €98.1M |
| Adjustments For Finance Income Cost | -€9.1M | -€4.9M |
| Adjustments For Gains Losses On Fair Value Adjustment Investment Property | €5.2M | €11.5M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €12.5M | €17.0M |
| Adjustments For Increase Decrease In Trade and Other Payables | -€59.9M | -€2.1M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€8.4M | €0 |
| Adjustments For Provisions | €798.0K | €3.1M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€1.4M | -€81.0K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | €29.0K | €6.0K |
| Cash Flows From Used In Operations Before Changes In Working Capital | €529.4M | €473.6M |
| Changes In Equity | €120.2M | €0 |
| Comprehensive Income Attributable To Noncontrolling Interests | €61.5M | €21.9M |
| Comprehensive Income Attributable To Owners of Parent | €48.8M | €43.6M |
| Current Financial Assets | €20.1M | €10.9M |
| Current Financial Liabilities | €225.8M | €178.8M |
| Current Tax Assets | €9.5M | €4.3M |
| Current Tax Liabilities | €8.0M | €5.6M |
| Deferred Tax Assets | €271.6M | €275.5M |
| Dividends Received Classified As Investing Activities | €0 | €60.0K |
| Equity and Liabilities | €3.62B | €3.94B |
| Finance Income | €9.9M | €5.0M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €7.3M | €10.5M |
| Income Tax Relating To Availableforsale Financial Assets of Other Comprehensive Income | €1.0K | €0 |
| Income Taxes Paid Refund Classified As Operating Activities | -€21.2M | -€13.6M |
| Increase Decrease In Cash and Cash Equivalents | -€48.3M | €11.1M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -€7.9M | -€1.1M |
| Increase Decrease Through Other Contributions By Owners | €3.3M | €2.3M |
| Increase Decrease Through Transfers and Other Changes Equity | €0 | €0 |
| Interest Paid Classified As Financing Activities | €103.9M | €66.4M |
| Interest Received Classified As Investing Activities | €8.0M | €3.6M |
| Investment Accounted For Using Equity Method | €7.8M | €6.4M |
| Investment Property | €30.2M | €31.3M |
| Issued Capital | €324.8M | €332.9M |
| Liabilities | €3.09B | €3.58B |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €16.4M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €13.6M | €21.7M |
| Noncurrent Financial Assets | €154.5M | €176.1M |
| Noncurrent Financial Liabilities | €1.72B | €2.18B |
| Noncurrent Government Grants | €28.8M | €27.1M |
| Noncurrent Receivables | €9.5M | €6.7M |
| Other Comprehensive Income | €1.7M | €1.6M |
| Other Comprehensive Income Before Tax Availableforsale Financial Assets | €1.7M | €1.6M |
| Other Expense By Nature | €401.7M | €410.9M |
| Other Noncurrent Nonfinancial Liabilities | €13.8M | €13.1M |
| Payments To Acquire Or Redeem Entitys Shares | €5.6M | €10.7M |
| Proceeds From Disposal of Noncurrent Assets Or Disposal Groups Classified As Held For Sale and Discontinued Operations | €0 | €0 |
| Proceeds From Government Grants Classified As Financing Activities | €938.0K | €750.0K |
| Proceeds From Issue of Ordinary Shares | €500.0M | €0 |
| Proceeds From Issuing Shares | €3.2M | €2.3M |
| Proceeds From Noncurrent Borrowings | €197.8M | €0 |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €31.0K | €0 |
| Proceeds From Sales of Investment Property | €27.4M | €1.7M |
| Proceeds From Sales of Investments Accounted For Using Equity Method | €9.3M | €0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €46.4M | €1.3M |
| Profit Loss From Continuing Operations | €108.6M | €63.9M |
| Profit Loss From Continuing Operations Attributable To Noncontrolling Interests | €61.5M | €21.9M |
| Profit Loss From Continuing Operations Attributable To Ordinary Equity Holders of Parent Entity | €47.1M | €42.0M |
| Profit Loss From Discontinued Operations | €0 | €0 |
| Profit Loss From Discontinued Operations Attributable To Noncontrolling Interests | €0 | €0 |
| Profit Loss From Discontinued Operations Attributable To Ordinary Equity Holders of Parent Entity | €0 | €0 |
| Purchase of Financial Instruments Classified As Investing Activities | €14.2M | €1.2M |
| Purchase of Interests In Investments Accounted For Using Equity Method | €2.9M | €1.1M |
| Purchase of Investment Property | €345.0K | €73.0K |
| Purchase of Investments Other Than Investments Accounted For Using Equity Method | €512.0K | €0 |
| Repayments of Bonds Notes and Debentures | €179.9M | €168.4M |
| Retained Earnings | -€261.9M | -€309.9M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net of Tax | €0 | €0 |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €1.4M | €81.0K |
| Share Premium | €3.8M | €3.8M |
Every line item above is a fact tagged in EROSKI SCOOP's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.